Blood purification beyond dialysis
Peer-Reviewed Publication
Updates every hour. Last Updated: 27-May-2026 04:15 ET (27-May-2026 08:15 GMT/UTC)
Sepsis and septic shock are the leading causes of death in intensive care units worldwide. Controlling the dysregulated host response that drives inflammation, hemodynamic collapse, and multiple organ failure is challenging. In a comprehensive narrative review, Italian and French researchers examine the clinical applications of the oXiris® membrane, an advanced extracorporeal blood purification filter designed to combine continuous renal replacement therapy (CRRT) with targeted removal of inflammatory mediators and bacterial endotoxins in critically ill patients.
As survival rates for female-specific cancers continue to rise, therapy-related myeloid neoplasms (t-MN) have become a critical long-term complication threatening survivors’ health. This systematic review by the team from Union Hospital summarizes the multi-factorial pathogenesis of t-MN, analyzes current treatment dilemmas, and puts forward female-focused management strategies. It provides a comprehensive theoretical framework for clinical precision prevention, early monitoring and targeted intervention of t-MN.
Glioma remains one of the deadliest brain cancers, characterized by aggressive growth and limited treatment options. In a new study, researchers from Ningxia Medical University uncovered that choline kinase alpha (CHKA) directly interacts with the epidermal growth factor receptor (EGFR) to activate the MAPK signaling pathway, thereby promoting glioma cell proliferation, migration, and invasion. This discovery sheds light on a previously unrecognized oncogenic axis, the CHKA/EGFR/MAPK pathway, offering fresh opportunities for targeted glioma therapy.
Researchers from the Biomedical Data Science Laboratory (BDSLab) at the ITACA Institute of the Universitat Politècnica de València have developed a new method based on magnetic resonance imaging that enables objective quantification of the growth of the most aggressive brain tumours, particularly glioblastoma.
The study, published in the scientific journal Medical Physics, addresses one of the main clinical challenges in the diagnosis and treatment of this tumour: its high capacity to infiltrate healthy brain tissue.
In their work, the UPV's BDSLab team presents a new biomarker, the Dynamic Infiltration Rate (DIR), capable of identifying different patterns of tumour growth and independently predicting patient survival.